Skip to main content

Radiation and Chemotherapy with Ipilimumab followed by Nivolumab for Patients with Stage III Unresectable NSCLC

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

H. Lee Moffitt Cancer Center & Research Institute

Start Date

May 13, 2019

End Date

June 30, 2024
 

Administered By

Duke Cancer Institute

Awarded By

H. Lee Moffitt Cancer Center & Research Institute

Start Date

May 13, 2019

End Date

June 30, 2024